The adipocytokines such as IL-1β, leptin, and resistin released by the adipocytes control insulin sensitivity and inflammation, which also take part in the pathogenesis of NAFLD and its progression to NASH (Fjære et al. 2019; Silva et al. 2020). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.